Lebanon is the 2nd largest market in the number of studies representing 19% of the clinical research market in the Levant/GCC region, for the year 2022.
With over 160 studies since 2009,
CD Log has doubled its business within the last 5 years and captured 27% of interventional drug studies running in Lebanon in 2022.
Executive team completed the Risk Management Certification.
QA Executives were certified as Internationally Qualified Clinical Research Auditor by IAOCR.
Frozen Storage Available for (-25)-(-15)C
During the COVID-19 pandemic, DTP deliveries ensured patients' treatment continuity.
Celebration of the 10th Anniversary with colleagues and friends.